Bharat Parenterals Ltd.
Snapshot View

345.05 -19.10 ▼-5.3%

03 February 2023, 04:01:00 PM
Volume: 2,070

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.bplindia.in
Market Cap 199.31 Cr.
Enterprise Value(EV) 235.57 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 28.52 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 12.10 Trailing Twelve Months Ending 2022-09
Industry PE 32.22 Trailing Twelve Months Ending 2022-09
Book Value / Share 306.52 Trailing Twelve Months Ending 2022-09
Price to Book Value 1.13 Calculated using Price: 345.05
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.58 Cr. 5,774,666 Shares
FaceValue 10
Company Profile
The company is engaged in to the business of the Pharmaceuticals & Drugs.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-5.25%
1 Week
+7.78%
1 Month
+5.84%
3 Month
-0.56%
6 Month
+1.49%
1 Year
-22.52%
2 Year
-7.24%
5 Year
10 Year
7 years 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 11.38 11.45 13.35 25.47 22.76 15.53 13.46
Return on Capital Employed (%) 14.23 11.47 18.10 39.30 30.83 20.24 17.18
Return on Assets (%) 5.37 5.99 7.61 14.71 13.94 10.52 9.80

Balance Sheet View Details >>

Particulars 8 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 57 64 73 94 118 144 166 177
Non Curr. Liab. 7 3 0 4 3 11 14 12
Curr. Liab. 56 43 57 61 66 44 42 95
Minority Int. 0 4 22
Equity & Liab. 120 110 130 159 188 199 226 306
Non Curr. Assets 49 46 39 41 56 51 82 119
Curr. Assets 72 64 91 118 132 148 144 186
Misc. Exp. not W/O
Total Assets 120 110 130 159 188 199 226 306

Profit Loss View Details >>

Particulars 8 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 124 111 137 220 228 205 212 199
Other Income 5 8 7 13 12 9 8 11
Total Income 129 119 144 232 240 213 220 210
Total Expenditure -114 -105 -124 -191 -201 -179 -184 -181
PBIDT 15 14 19 42 40 34 36 29
Interest -1 -1 -1 -1 -1 -1 -1 -1
Depreciation -4 -6 -6 -6 -6 -6 -7 -6
Taxation -3 -1 -4 -13 -9 -7 -7 -6
Exceptional Items
PAT 6 7 9 21 24 20 21 16
Minority Interest 0 0 0
Share Associate
Other Related Items
Consolidated Net Profit 6 7 9 21 24 20 21 16
Adjusted EPS 11 12 16 37 42 36 36 29

Cash Flow View Details >>

Particulars 7 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -2 6 20 14 24 -1
Cash Fr. Inv. -2 -8 -9 -13 -43 -7
Cash Fr. Finan. -8 4 -4 -3 11 9
Net Change -11 2 7 -1 -8 2
Cash & Cash Eqvt 2 4 11 10 2 3

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 74.42 74.42 74.42 74.42 74.42 73.84 73.84 73.84 73.84
Public 25.58 25.58 25.58 25.58 25.58 26.16 26.16 26.16 26.16
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 13 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Confirmation Certificate pursuant to provisions of Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 duly sent and confirmed by Adroit Corporate Services Private Limited viz. Companys Registrar and Share Transfer Agent registered with Securities and Exchange Board of India for the period ended on 31st December 2022.
Sat, 31 Dec 2022
Closure of Trading Window
Pursuant to Companys Code of Conduct framed in accordance with the SEBI (Prohibition of Insider Trading) Regulations 2015 as amended the Trading Window for dealing in the securities of the company for all designated persons specified under the Code shall remain close form 02nd January 2023 onwards till 48 hours after the declaration of Unaudited Financial Results for the quarter ended 31st December 2022 (both days inclusive).
Sat, 12 Nov 2022
Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2022.
In compliance of Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Board of Directors of the Company in its meeting held on 12th November 2022 has considered and approved the Unaudited Financial Results for the Quarter and half year ended 30th September 2022 and taken on record Limited Review Report issued by the Statutory Auditors of the Company.In this respect we hereby enclose following:1. Unaudited Financial Results for the Quarter and Half year ended 30th September 2022.2. Limited Review Report on the said Financial Results.

Technical Scans View Details >>

Fri, 03 Feb 2023
High Delivery Percentage High Delivery Percentage
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Closing Below Previous Low Closing Below Previous Low
Close Above Last Week High Close Above Last Week High
High Increase in 1 Month High Increase in 1 Month

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 246,567.66 1,027.65 +2.0%
Cipla Ltd. 82,812.97 1,026.00 +0.1%
Divi's Laboratories Ltd. 76,573.08 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. 72,577.66 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. 61,039.46 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. 52,289.82 1,545.00 +0.3%
Abbott India Ltd. 44,198.55 20,800.00 +1.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 58.54 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-12 31.39 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 25.59 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.92 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.70 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.92 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-09 50.12 20,800.00 +1.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.46 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-12 3.65 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 6.31 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.30 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.20 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.20 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-09 16.28 20,800.00 +1.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 0.00 20,800.00 +1.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 20,800.00 +1.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 20,800.00 +1.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,800.00 +1.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 798.70 20,800.00 +1.5%

FAQ's On Bharat Parenterals Ltd.

What is Bharat Parenterals share price?

Can I buy Bharat Parenterals shares now?

What is the Market Cap of Bharat Parenterals?

What are the key metrics to analyse Bharat Parenterals?

What is the 52 Week High and Low of Bharat Parenterals?

What is the trend of Bharat Parenterals share price?